Signatera

AUSTIN, Texas, September 1, 2026 Natera announced publication of new clinical data in Blood Neoplasia supporting the prognostic and...

Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...

Austin, Texas – August 27, 2026 Natera and Angiex have entered a new collaboration to assess treatment response to...

AUSTIN, Texas, August 5, 2026 Natera, Inc. has submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)...

AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...

AUSTIN, Texas | May 2026 Natera, Inc. announced a new collaboration with Diakonos Oncology Corp. to utilize its personalized...

AUSTIN, Texas — May 27, 2026 Natera, Inc. announced the enrollment of the first patients in the SIGNAL-ER 101...

Austin, Texas, USA – May 21, 2026 Natera, Inc., a global leader in cell-free DNA testing and precision medicine,...